GlassScriptPrepare for your visit
Sherief Mansi
Pediatric Gastroenterology · Fort Worth, TX · NPI 1801215215
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,304.56
in general payments reported to CMS, 2019-2025 · $532 in 2025
The $532 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Who reported paying
General payments only, top 6 by amount.
- Neuraxis, INC. $567.07
- Qol Medical, LLC $298.32
- Boston Scientific Corporation $187.84
- Janssen Biotech, INC. $126.61
- Abbvie INC. $76.84
- Ardelyx, INC. $31.96
Drugs and devices associated with these payments
Tremfya Apollo Esg Nxt System Dupixent
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Sherief Mansi listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/4221561/sherief-mansi